{"id":"W4387003971","doi":"10.1016/s2152-2650(23)01733-0","title":"P-115 Progression-free survival of daratumumab vs. bortezomib triplet combination with lenalidomide and dexamethasone in transplant ineligible newly diagnosed multiple myeloma patients: a chart review study","year":2023,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Lenalidomide; Daratumumab; Bortezomib; Dexamethasone; Medicine; Multiple myeloma; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001658058,0.0003727811,0.002543412,0.001224882,0.0001501176,0.0007688133,0.0006567495,0.0003813657,0.00225014],"category_scores_gemma":[0.00224479,0.0002430379,0.003204938,0.00237183,0.0002277039,0.0005248154,0.0002877605,0.0005745211,0.000215418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009621291,"about_ca_system_score_gemma":0.001614992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003036224,"about_ca_topic_score_gemma":0.008445039,"domain_scores_codex":[0.9993767,0.0001645893,0.0002150391,0.00008953007,0.0001219026,0.00003223657],"domain_scores_gemma":[0.9984514,0.0006965215,0.0005605984,0.00003103049,0.0002163813,0.0000441283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01287926,0.0002227613,0.00820497,0.417043,0.02533071,0.0002253514,0.0002214224,0.0004015228,0.001469117,0.0004225169,0.01297936,0.5206],"study_design_scores_gemma":[0.02269697,0.01005728,0.16133,0.2492111,0.3424864,0.002973483,0.0008485139,0.0006027995,0.002134735,0.0006332992,0.2067835,0.0002420009],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005017837,0.9939161,0.00003783865,0.00008899112,0.00004977811,0.00007539136,0.0005127537,0.000003927278,0.0002974774],"genre_scores_gemma":[0.03546184,0.9630104,0.0002712656,0.0002694819,0.0000545047,0.00009273268,0.0006244965,0.000003452512,0.0002119023],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003036224,"threshold_uncertainty_score":0.008768737,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.081715692748588,"score_gpt":0.4021514274948764,"score_spread":0.3204357347462884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}